Psoriasis is an autoimmune disorder wherein skin cells start to rapidly multiply, resulting in scale-like patches on the skin’s surface. These patches can be itchy, red and inflamed.
Psoriasis has no known cure and can be difficult to manage. Despite numerous topical treatments for psoriasis, many patients continue to experience chronic itching and pain. However, some treatments can help in alleviating symptoms. Many people suffering from psoriasis are turning to cannabis for relief. Cannabis, including cannabinoids like CBD, is frequently used to treat pain and inflammation. Here’s everything you should know about using medical cannabis to treat psoriasis symptoms.
Symptoms of Psoriasis to Look Out For
Psoriasis symptoms and signs vary from person to person, but they typically include:
- Red skin patches covered with thick, silvery scales
- Skin spots that are smaller and scaly
- Dry, cracked skin that may itch or bleed
- Itching, burning, or soreness
- Nails that have been pitted, thickened, or ridged
- Joint pain and swelling
Psoriasis patches can range from a few small spots of scaly skin that resemble dandruff to severe eruptions that cover large areas of the body. The most commonly affected areas of the body are the ankles, elbows, face, knees (front and back), legs, lower back, palms, scalp, and soles of the feet. Most types of psoriasis flare up in cycles for a few weeks or months and then subside or even go into remission.
How Does it Work?
Cannabis is a plant that contains over 80 biologically active chemical compounds known as cannabinoids. Cannabis plants contain a plethora of chemicals known as cannabinoids. CBD and THC (tetrahydrocannabinol) are two well-known cannabinoids. CBD products in India are non-addictive, which means they will not get you high. THC, on the other hand, can produce a high. Cannabinoids work by influencing the endocannabinoid system, which aids in the maintenance of your body’s health. Your endocannabinoid system has an impact on many parts of your body, including your digestive system, brain, and skin.
Is it better to treat psoriasis with a CBD topical cream or a CBD oil?
Psoriasis flare-ups can be triggered by a variety of factors, including illness, stress, and external factors such as allergies, it’s not always clear which form of CBD will provide the most relief. Here are some things to think about.
Face skin is delicate and sensitive, not to mention acne-prone. Consider a CBD product specifically formulated for the face if you have psoriasis on the face and want to treat it topically. Alternatively, this could be a good time to experiment with CBD oil.
When it comes to psoriasis of the scalp, which can be itchy and uncomfortable like dandruff, you want CBD products that will either soothe or not irritate your scalp. In these cases, CBD capsules might do the trick.
When stress is causing psoriasis flare-ups, look for the right kind of CBD to help you relax. Many users find that CBD oil works well as a preventative measure.
CBD oil or CBD edibles are frequently the best preventative strategy for psoriasis patients whose disease is triggered by immune issues.
Which CBD Product is best for psoriasis?
There is no single solution—find what works best for you. Remember, before beginning any new treatment for psoriasis (or any other health condition), consult with your doctor or another healthcare provider. Although CBD is widely recognized as safe, the industry is unregulated. Look for third-party testing results, and keep in mind that substituting CBD for another medication may have an effect on your health.
So we are saying,
One must know for CBD-based products to be legal in India, it needs to contain within or less than 0.3% of THC. Since regulation around cannabis is not that strong, many companies mislabel their product and sell products that contain higher THC content. Hempstrol is one such brand from where you can buy cannabis products in India that has a license from the Indian government and thus, they strictly ensure their CBD products in India contains less than 0.3% of THC.
